Articles from ProtaGene

HEIDELBERG, Germany, and BOSTON, Massachusetts, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ProtaGene, a leading global contract research organization (CRO) specializing in advanced analytics for biologics and cell and gene therapies, today announced the appointment of Matthias Bucerius, PhD, as Chief Executive Officer, effective immediately.